1. Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration. (April 2021) Authors: Bantseev, Vladimir; Horvath, Joshua; Barteselli, Giulio; Ranade, Shrirang; Maia, Mauricio; Yadav, Daniela Bumbaca; Schuetz, Chris; Shelton, Amy; Booler, Helen S. Other Names: Ramos Meg Ferrell guest-editor.; Schafer Kenneth guest-editor.; Sorden Steven guest-editor. Journal: Toxicologic pathology Issue: Volume 49:Number 3(2021) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗